In a recent report, we showed that hollow human H-ferritin nanoparticles (HFn lacking an iron core) specifically recognize tumor cells expressing high levels of HFn receptor (transferrin receptor 1, TfR1)28 and thus deliver the complex into lysosomes via receptor-mediated endocytosis29. Here, FTH1 is linked to neoplasm.